Financials
- Market Capitalization 1.54 B
- Employee 159
- Founded 1996
- CEO N/A
- Website www.inva.com
- Headquarter Delaware, United States
- FIGI BBG000CG9XT7
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
6.06
市销率
4.12
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2084 | ABSI Absci Corporation - Common Stock | 9.49 USD | -1.86% | -16.68% | +18.18% | +167.32% | 1.63 B USD | ||
| 2125 | STOK Stoke Therapeutics, Inc. - Common Stock | 23.55 USD | -2.48% | -2.48% | -19.84% | -22.46% | 1.52 B USD | ||
| 2136 | QURE uniQure N.V. - Ordinary Shares | 21.21 USD | -2.88% | -2.17% | -52.09% | -65.46% | 1.47 B USD | ||
| 2140 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 15.19 USD | -0.72% | +5.12% | +5.19% | -52.46% | 1.50 B USD |